Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $14.97M by Medicaid between Jan 2018 and Dec 2024, across 140 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
SAN FRANCISCO, CA 94115
SAN FRANCISCO, CA 94115
33aNPI1134299522assigned 11/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.97M
24GClaims291,572
24DCodes billed140
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#149 of 410
Median peer was paid$6.90M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,892 | $135K | |
| 2019 | 31,046 | $182K | |
| 2020 | 26,993 | $1.18M | |
| 2021 | 53,648 | $3.35M | |
| 2022 | 38,183 | $2.40M | |
| 2023 | 49,970 | $3.02M | |
| 2024incomplete | 75,840 | $4.70M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 5,661 | 5,310 | $4.47M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 5,225 | 5,041 | $2.72M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 5,444 | 5,251 | $1.61M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 537 | 517 | $747K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.0% | 1,490 | 1,467 | $746K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.6% | 7,173 | 6,367 | $687K |
| 0002A | 2.1% | 7,884 | 7,884 | $312K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 3,191 | 3,122 | $285K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 1,924 | 1,871 | $270K |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 3,175 | 3,092 | $269K |
| 0001A | 1.6% | 8,244 | 8,244 | $234K | |
| G0378 | Hospital observation service, per hour | 1.4% | 451 | 300 | $203K |
128 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 153 | $145K |
| 0270 | <1% | 3,164 | $140K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 115 | $139K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,199 | $139K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,626 | $133K |
| 0450 | Emergency room services | <1% | 3,807 | $130K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,895 | $94K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,355 | $84K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,446 | $81K |
| 83880 | <1% | 2,945 | $77K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,556 | $77K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 535 | $76K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,097 | $70K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 275 | $68K |
| 81001 | <1% | 13,442 | $45K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,032 | $40K |
| 86900 | <1% | 601 | $37K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 110 | $36K |
| 80051 | <1% | 9,268 | $35K | |
| 82565 | <1% | 11,255 | $33K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,069 | $31K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 377 | $28K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 758 | $28K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,902 | $27K |
| 84460 | <1% | 7,856 | $25K | |
| 82247 | <1% | 7,829 | $25K | |
| 76830 | Ultrasound, transvaginal | <1% | 136 | $22K |
| 84450 | <1% | 7,157 | $22K | |
| 99199 | Unlisted special service, procedure or report | <1% | 410 | $20K |
| 82947 | <1% | 9,520 | $19K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 14 | $18K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 894 | $18K |
| 84520 | <1% | 9,399 | $18K | |
| 81003 | <1% | 7,476 | $17K | |
| 83690 | <1% | 5,548 | $17K | |
| 0637 | <1% | 18,578 | $17K | |
| 85652 | <1% | 4,495 | $16K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,372 | $15K |
| 84484 | <1% | 3,067 | $15K | |
| 84075 | <1% | 6,015 | $14K | |
| 84702 | <1% | 1,121 | $14K | |
| 93976 | <1% | 40 | $13K | |
| 71250 | <1% | 71 | $12K | |
| 83735 | <1% | 3,414 | $12K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 286 | $12K |
| 86901 | <1% | 601 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 601 | $11K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 81 | $10K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 453 | $10K |
| 73560 | <1% | 111 | $10K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 401 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 402 | $9K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,888 | $9K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 25 | $9K |
| 86850 | <1% | 317 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,233 | $8K |
| 80306 | <1% | 785 | $7K | |
| 73610 | <1% | 57 | $7K | |
| 85610 | <1% | 2,658 | $6K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,440 | $6K |
| 93971 | <1% | 46 | $6K | |
| 73630 | <1% | 58 | $6K | |
| 70486 | <1% | 25 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 26 | $5K |
| 82077 | <1% | 863 | $5K | |
| 84100 | <1% | 1,974 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 346 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,344 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,722 | $5K |
| 82962 | <1% | 2,203 | $4K | |
| 87088 | <1% | 1,284 | $4K | |
| 84703 | <1% | 1,454 | $4K | |
| 85027 | <1% | 900 | $4K | |
| 87631 | <1% | 240 | $4K | |
| 83605 | <1% | 1,004 | $4K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 92 | $4K |
| 84132 | <1% | 662 | $4K | |
| 0031A | <1% | 88 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 416 | $3K |
| 70491 | <1% | 12 | $3K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 169 | $3K |
| J3490 | Unclassified drugs | <1% | 1,218 | $3K |
| 85379 | <1% | 473 | $3K | |
| 73030 | <1% | 28 | $2K | |
| 82310 | <1% | 401 | $2K | |
| 82248 | <1% | 477 | $2K | |
| 73130 | <1% | 12 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,632 | $2K |
| 87040 | <1% | 397 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 553 | $2K |
| 0250 | <1% | 3,263 | $2K | |
| 73502 | <1% | 12 | $1K | |
| 84295 | <1% | 208 | $1K | |
| 82570 | <1% | 196 | $1K | |
| C1769 | Guide wire | <1% | 32 | $1K |
| 85730 | <1% | 164 | $1K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 66 | $1K |
| 87449 | <1% | 55 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 338 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 122 | $1K |
| 87324 | <1% | 55 | $985.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 20 | $897.05 |
| 96376 | <1% | 191 | $882.87 | |
| 86140 | <1% | 213 | $846.67 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 20 | $813.56 |
| A4217 | Sterile water/saline, 500 ml | <1% | 47 | $782.60 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,291 | $767.05 |
| 84156 | <1% | 193 | $749.45 | |
| 80179 | <1% | 142 | $644.58 | |
| Z7502 | <1% | 78 | $550.33 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 53 | $542.95 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 258 | $440.63 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 140 | $388.58 |
| 85378 | <1% | 71 | $346.05 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 97 | $324.29 |
| J1815 | Injection, insulin, per 5 units | <1% | 35 | $322.83 |
| 97162 | <1% | 25 | $285.94 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 36 | $260.93 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 140 | $236.57 |
| 0710 | <1% | 753 | $203.53 | |
| 82040 | <1% | 35 | $189.02 | |
| 82550 | <1% | 13 | $60.74 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 43 | $42.06 |
| 0258 | <1% | 213 | $19.32 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 18 | $0.60 |
| 0370 | 0% | 659 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 12 | $0.00 |
| 76376 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGROEPPER, RON (SR VP, AREA MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Hospitals | South San Francisco, CA | $9.30M |
| Kaiser Foundation Hospitals | San Francisco, CA | $633K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.